This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Palatinal maxillary operation
K11_MAXIL_CANINE_OPER
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersPre-conditions: EVENT_AGE<16 Registry filters:
2 out of 7 registries used, show all original rules. |
354 |
4. Check minimum number of eventsNone |
354 |
5. Include endpointsNone |
354 |
6. Filter based on genotype QC (FinnGen only) |
338 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF7
Palatinal maxillary operation
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 338 | 263 | 75 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.03 |
| Median age at first event (years) | 13.44 | 13.33 | 13.82 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 354
- Matched controls
- 3540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ECA00
NOMESCO Finland
Surgical exposure of tooth
4503599627370496.0
307.7
352
5
K01.12
ICD-10 Finland
Retained canine with obstruction in the upper jaw
75.2
192.2
106
20
K01.0
ICD-10 Finland
Embedded teeth
19.0
144.9
135
111
K07.35
ICD-10 Finland
Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth
27.9
130.5
95
46
SJD00
NOMESCO Finland
Removal and/or reactivation of orthodontic arch wire
10.9
117.3
215
440
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
10.7
115.3
202
391
SJD10
NOMESCO Finland
Placement of orthodontic arch wire
9.7
105.3
210
463
SJC50
NOMESCO Finland
Removal of fixed orthodontic appliance with at least 7 brackets
8.1
87.2
180
399
SJD20
NOMESCO Finland
Placement of modified orthodontic arch wire
7.3
73.3
150
322
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
6.6
56.7
117
247
SBB10
NOMESCO Finland
Dental impressions
5.5
55.5
223
837
SJB00
NOMESCO Finland
Fitting of removable appliance incl. patient instructions
5.3
52.1
163
494
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
5.7
51.4
127
314
SJD30
NOMESCO Finland
Demanding placement of orthodontic arch wire
6.5
50.5
100
201
SJD40
NOMESCO Finland
Placement of prefabricated palatal or lingual arch
4.9
45.5
148
455
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
4.7
42.8
141
435
SXB00
NOMESCO Finland
Removal of sutures from oral mucosa
7.1
40.0
67
112
SJX10
NOMESCO Finland
Orthodontic treatment/control appointment, short
3.7
32.2
172
722
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
3.6
30.6
153
612
SJC10
NOMESCO Finland
Orthodontic band in one tooth
3.9
27.6
104
341
SXC05
NOMESCO Finland
Other oral or dental procedure
3.4
26.2
143
594
SJC40
NOMESCO Finland
Removal of fixed orthodontic appliance with at most 6 brackets
3.4
24.5
120
464
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
4.0
24.0
81
244
SAA04
NOMESCO Finland
Special examination of mouth
3.5
23.7
107
392
SJX20
NOMESCO Finland
Orthodontic treatment/control appointment
3.4
22.7
106
395
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.4
20.9
94
341
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
3.4
20.5
89
315
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.0
19.6
249
1575
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
3.0
18.4
105
435
OIKH, ,
NOMESCO Finland
2.9
16.9
98
407
WZA90
NOMESCO Finland
Other medical or dental certificate
2.6
16.8
172
953
EB1MA
NOMESCO Finland
Cephalometry with X-ray
3.0
16.6
90
360
EMAK, ,
NOMESCO Finland
6.2
16.5
29
50
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
3.0
14.9
79
311
SJD50
NOMESCO Finland
Placement of prefabricated palatal or lingual arch, dentist-made
4.8
14.4
34
77
EBA00
NOMESCO Finland
Extraction of tooth
2.4
13.6
233
1575
OIKK, ,
NOMESCO Finland
2.5
13.2
114
571
WX110
NOMESCO Finland
Infiltration anesthesia
3.8
12.9
323
2589
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.0
12.2
36
97
OIKAL, ,
NOMESCO Finland
3.2
11.8
51
177
SJC00
NOMESCO Finland
Bondable bracket or other fixed attachement
17.8
11.3
17
10
SAALT, ,
NOMESCO Finland
3.3
9.2
36
117
SAA03
NOMESCO Finland
Extended examination of mouth
2.1
9.0
264
2043
K01.13
ICD-10 Finland
Retained canine with obstruction in the lower jaw
28.3
8.5
11
*
K03.30
ICD-10 Finland
Internal granuloma of pulp
+∞
8.4
8
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
8.2
189
1326
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
2.5
7.6
52
229
K01.19
ICD-10 Finland
Retained tooth with obstruction barrier UNS
25.6
7.6
10
*
K01.1
ICD-10 Finland
Impacted teeth
6.7
7.5
18
28
K00.68
ICD-10 Finland
Other disturbance in the tooth eruption
2.6
6.9
41
169
OIKRE, ,
NOMESCO Finland
3.7
6.8
22
63
K01.10
ICD-10 Finland
Retained front tooth with obstruction in the upper jaw
23.0
6.7
9
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.0
6.4
80
451
WZC00
NOMESCO Finland
Treatment plan or consultation
1.8
6.4
193
1432
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.8
6.2
186
1371
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth
K07.35 [2000502780]
K07.35 [2000502780]
1.6e+00
3.5e+00
3.8e+00
1.0e+50
—
3.6e+00
2.8e+00
cases:4.55%
controls:0.91%
cases:13.35%
controls:0.48%
cases:5.97%
controls:0.14%
cases:5.68%
controls:0.00%
—
—
cases:13.64%
controls:0.43%
cases:14.45%
controls:1.01%
16
32
336
3475
47
17
305
3490
21
5
331
3502
20
0
332
3507
—
48
15
304
3470
49
34
290
3349
Placement of orthodontic arch wire
SJD10 [2001310438]
SJD10 [2001310438]
4.9e-01
1.8e+00
2.3e+00
—
3.0e+00
3.1e+00
2.4e+00
cases:9.66%
controls:6.13%
cases:20.74%
controls:4.02%
cases:7.39%
controls:0.77%
—
—
cases:10.51%
controls:0.60%
cases:42.61%
controls:3.39%
cases:36.58%
controls:4.91%
34
215
318
3292
73
141
279
3366
26
27
326
3480
—
37
21
315
3486
150
118
202
3367
124
166
215
3217
Placement of modified orthodontic arch wire
SJD20 [2001310439]
SJD20 [2001310439]
8.6e-02
1.7e+00
2.1e+00
—
3.4e+00
2.7e+00
2.2e+00
cases:3.41%
controls:3.14%
cases:9.09%
controls:1.82%
cases:2.84%
controls:0.34%
—
—
cases:6.53%
controls:0.23%
cases:22.16%
controls:1.84%
cases:28.02%
controls:3.99%
12
110
340
3397
32
64
320
3443
10
12
342
3495
—
23
8
329
3499
78
64
274
3421
95
135
244
3248
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
SJC01 [2001310428]
SJC01 [2001310428]
2.5e-01
1.2e+00
2.3e+00
1.0e+50
3.2e+00
3.0e+00
2.2e+00
cases:4.83%
controls:3.79%
cases:7.95%
controls:2.57%
cases:2.84%
controls:0.29%
cases:17.05%
controls:0.00%
cases:5.68%
controls:0.26%
cases:33.52%
controls:2.35%
cases:29.50%
controls:4.58%
17
133
335
3374
28
90
324
3417
10
10
342
3497
60
0
292
3507
20
9
332
3498
118
82
234
3403
100
155
239
3228
Removal and/or reactivation of orthodontic arch wire
SJD00 [2001310437]
SJD00 [2001310437]
2.3e-01
1.5e+00
1.8e+00
—
2.5e+00
3.1e+00
2.6e+00
cases:6.53%
controls:5.25%
cases:17.05%
controls:4.19%
cases:5.68%
controls:1.03%
—
—
cases:11.93%
controls:1.14%
cases:46.31%
controls:3.67%
cases:43.07%
controls:5.56%
23
184
329
3323
60
147
292
3360
20
36
332
3471
—
42
40
310
3467
163
128
189
3357
146
188
193
3195
Placement of prefabricated palatal or lingual arch
SJD40 [2001310441]
SJD40 [2001310441]
1.9e-01
2.0e+00
2.9e+00
—
3.3e+00
1.4e+00
1.7e+00
cases:6.82%
controls:5.73%
cases:14.49%
controls:2.34%
cases:4.55%
controls:0.26%
—
—
cases:4.55%
controls:0.17%
cases:7.95%
controls:2.12%
cases:20.94%
controls:4.76%
24
201
328
3306
51
82
301
3425
16
9
336
3498
—
16
6
336
3501
28
74
324
3411
71
161
268
3222
Dentistry
C5 [903277]
C5 [903277]
1.9e-01
1.8e+00
3.4e+00
1.0e+50
3.6e+00
1.5e+00
8.1e-01
cases:6.82%
controls:5.70%
cases:13.35%
controls:2.42%
cases:7.10%
controls:0.26%
cases:34.38%
controls:0.00%
cases:10.51%
controls:0.31%
cases:9.09%
controls:2.27%
cases:9.44%
controls:4.43%
24
200
328
3307
47
85
305
3422
25
9
327
3498
121
0
231
3507
37
11
315
3496
32
79
320
3406
32
150
307
3233
Orthodontic treatment/control appointment, short
SJX10 [2001310452]
SJX10 [2001310452]
4.6e-01
1.5e+00
2.2e+00
—
2.6e+00
1.6e+00
2.0e+00
cases:17.90%
controls:12.06%
cases:19.60%
controls:5.16%
cases:5.97%
controls:0.71%
—
—
cases:9.09%
controls:0.74%
cases:17.05%
controls:3.99%
cases:20.65%
controls:3.40%
63
423
289
3084
69
181
283
3326
21
25
331
3482
—
32
26
320
3481
60
139
292
3346
70
115
269
3268
Embedded teeth
K01.0 [45548133]
K01.0 [45548133]
2.2e+00
—
—
1.0e+50
1.0e+50
4.0e+00
2.5e+00
cases:1.99%
controls:0.23%
—
—
—
—
cases:22.73%
controls:0.00%
cases:7.10%
controls:0.00%
cases:7.39%
controls:0.14%
cases:5.60%
controls:0.47%
7
8
345
3499
—
—
80
0
272
3507
25
0
327
3507
26
5
326
3480
19
16
320
3367
Positioning and fixed attachment of brackets, extensive
SJC03 [2001310430]
SJC03 [2001310430]
3.5e-01
1.7e+00
3.1e+00
—
—
2.2e+00
1.5e+00
cases:5.11%
controls:3.65%
cases:9.38%
controls:1.77%
cases:3.69%
controls:0.17%
—
—
—
—
cases:11.36%
controls:1.35%
cases:10.62%
controls:2.63%
18
128
334
3379
33
62
319
3445
13
6
339
3501
—
—
40
47
312
3438
36
89
303
3294
Positioning and fixed attachment of brackets
SJC02 [2001310429]
SJC02 [2001310429]
8.4e-02
1.6e+00
2.0e+00
—
—
2.7e+00
2.2e+00
cases:3.13%
controls:2.88%
cases:7.10%
controls:1.51%
cases:2.27%
controls:0.31%
—
—
—
—
cases:16.19%
controls:1.26%
cases:16.81%
controls:2.16%
11
101
341
3406
25
53
327
3454
8
11
344
3496
—
—
57
44
295
3441
57
73
282
3310
Specialty-specific consultation based on referral by dentist or doctor
WZC05 [2001310886]
WZC05 [2001310886]
8.9e-01
2.0e+00
2.5e+00
—
—
1.3e+00
1.3e+00
cases:9.66%
controls:4.22%
cases:10.80%
controls:1.60%
cases:2.27%
controls:0.20%
—
—
—
—
cases:4.83%
controls:1.35%
cases:9.14%
controls:2.66%
34
148
318
3359
38
56
314
3451
8
7
344
3500
—
—
17
47
335
3438
31
90
308
3293
Other oral or dental procedure
SXC05 [2001310586]
SXC05 [2001310586]
2.9e-01
9.2e-01
2.2e+00
—
1.8e+00
1.4e+00
1.4e+00
cases:4.55%
controls:3.45%
cases:7.10%
controls:2.97%
cases:3.41%
controls:0.40%
—
—
cases:4.26%
controls:0.74%
cases:11.93%
controls:3.27%
cases:27.43%
controls:8.45%
16
121
336
3386
25
104
327
3403
12
14
340
3493
—
15
26
337
3481
42
114
310
3371
93
286
246
3097
Dental impressions
SBB10 [2001310299]
SBB10 [2001310299]
4.4e-01
1.8e+00
3.0e+00
—
1.4e+00
9.8e-01
1.8e+00
cases:17.05%
controls:11.72%
cases:23.01%
controls:4.93%
cases:7.10%
controls:0.37%
—
—
cases:1.70%
controls:0.43%
cases:12.50%
controls:5.08%
cases:38.64%
controls:9.07%
60
411
292
3096
81
173
271
3334
25
13
327
3494
—
6
15
346
3492
44
177
308
3308
131
307
208
3076
Therapeutic intervention or check-up related to orthodontic treatment, restricted
SJX11 [2001310453]
SJX11 [2001310453]
1.9e-01
8.7e-01
1.7e+00
—
2.2e+00
8.5e-01
1.4e+00
cases:7.39%
controls:6.19%
cases:10.23%
controls:4.53%
cases:3.41%
controls:0.66%
—
—
cases:5.40%
controls:0.60%
cases:11.93%
controls:5.48%
cases:27.73%
controls:8.48%
26
217
326
3290
36
159
316
3348
12
23
340
3484
—
19
21
333
3486
42
191
310
3294
94
287
245
3096
Demanding placement of orthodontic arch wire
SJD30 [2001310440]
SJD30 [2001310440]
4.5e-01
6.3e-01
1.7e+00
—
2.6e+00
2.2e+00
2.1e+00
cases:2.27%
controls:1.45%
cases:2.27%
controls:1.23%
cases:1.42%
controls:0.26%
—
—
cases:3.13%
controls:0.23%
cases:10.80%
controls:1.35%
cases:19.47%
controls:2.81%
8
51
344
3456
8
43
344
3464
5
9
347
3498
—
11
8
341
3499
38
47
314
3438
66
95
273
3288
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
-2.2e-02
2.5e-01
8.4e-01
4.5e+00
1.4e+00
1.5e-01
-8.6e-04
cases:56.53%
controls:57.09%
cases:66.19%
controls:60.31%
cases:44.32%
controls:25.52%
cases:51.70%
controls:1.17%
cases:57.10%
controls:25.58%
cases:69.89%
controls:66.54%
cases:78.47%
controls:78.48%
199
2002
153
1505
233
2115
119
1392
156
895
196
2612
182
41
170
3466
201
897
151
2610
246
2319
106
1166
266
2655
73
728
Orthodontic treatment/control appointment
SJX20 [2001310454]
SJX20 [2001310454]
6.8e-02
1.0e+00
—
—
2.3e+00
1.4e+00
1.7e+00
cases:9.38%
controls:8.81%
cases:7.39%
controls:2.77%
—
—
—
—
cases:4.55%
controls:0.48%
cases:8.81%
controls:2.35%
cases:10.62%
controls:2.16%
33
309
319
3198
26
97
326
3410
—
—
16
17
336
3490
31
82
321
3403
36
73
303
3310
Therapeutic intervention or check-up related to orthodontic treatment
SJX21 [2001310455]
SJX21 [2001310455]
2.6e-01
8.5e-01
—
—
2.0e+00
1.5e+00
1.6e+00
cases:6.25%
controls:4.90%
cases:6.82%
controls:3.02%
—
—
—
—
cases:2.84%
controls:0.40%
cases:13.64%
controls:3.56%
cases:23.60%
controls:6.15%
22
172
330
3335
24
106
328
3401
—
—
10
14
342
3493
48
124
304
3361
80
208
259
3175
Simple examination of mouth
SAA01 [2001310274]
SAA01 [2001310274]
9.3e-02
6.8e-01
1.8e+00
1.0e+50
2.5e+00
8.0e-01
3.6e-01
cases:17.90%
controls:16.57%
cases:14.77%
controls:8.10%
cases:3.41%
controls:0.60%
cases:7.39%
controls:0.00%
cases:7.95%
controls:0.68%
cases:13.92%
controls:6.74%
cases:31.86%
controls:24.59%
63
581
289
2926
52
284
300
3223
12
21
340
3486
26
0
326
3507
28
24
324
3483
49
235
303
3250
108
832
231
2551
Orthodontic band in one tooth
SJC10 [2001310432]
SJC10 [2001310432]
3.7e-01
2.1e+00
—
—
—
1.8e+00
1.7e+00
cases:8.24%
controls:5.85%
cases:11.08%
controls:1.51%
—
—
—
—
—
—
cases:5.68%
controls:1.03%
cases:9.14%
controls:1.86%
29
205
323
3302
39
53
313
3454
—
—
—
20
36
332
3449
31
63
308
3320
Special examination of mouth
SAA04 [2001310277]
SAA04 [2001310277]
3.6e-01
2.6e+00
2.7e+00
—
—
7.8e-01
7.1e-01
cases:7.39%
controls:5.28%
cases:12.78%
controls:1.06%
cases:2.56%
controls:0.17%
—
—
—
—
cases:1.99%
controls:0.92%
cases:7.08%
controls:3.61%
26
185
326
3322
45
37
307
3470
9
6
343
3501
—
—
7
32
345
3453
24
122
315
3261
Emergency visit or other similar visit involving procedures
WYA05 [2001310871]
WYA05 [2001310871]
1.5e-01
6.4e-01
1.0e+00
—
3.0e+00
1.4e+00
7.6e-01
cases:11.65%
controls:10.21%
cases:7.67%
controls:4.19%
cases:1.42%
controls:0.51%
—
—
cases:5.68%
controls:0.29%
cases:13.92%
controls:3.93%
cases:19.47%
controls:10.14%
41
358
311
3149
27
147
325
3360
5
18
347
3489
—
20
10
332
3497
49
137
303
3348
66
343
273
3040
Separate planning of oral and dental treatment, demanding
SAC02 [2001310284]
SAC02 [2001310284]
3.3e-01
2.0e+00
—
—
—
1.6e+00
1.5e+00
cases:6.25%
controls:4.56%
cases:10.23%
controls:1.48%
—
—
—
—
—
—
cases:3.41%
controls:0.69%
cases:5.31%
controls:1.27%
22
160
330
3347
36
52
316
3455
—
—
—
12
24
340
3461
18
43
321
3340
Spacing, abnormal of tooth or teeth
K07.30 [2000502776]
K07.30 [2000502776]
3.5e-01
9.6e-01
7.2e-01
—
1.9e+00
1.1e+00
1.0e+00
cases:10.80%
controls:7.87%
cases:11.65%
controls:4.82%
cases:2.56%
controls:1.25%
—
—
cases:4.83%
controls:0.74%
cases:11.08%
controls:3.90%
cases:15.34%
controls:6.18%
38
276
314
3231
41
169
311
3338
9
44
343
3463
—
17
26
335
3481
39
136
313
3349
52
209
287
3174
Teeth/gum disease
D82 [2002000380]
D82 [2002000380]
9.3e-03
8.0e-01
1.9e+00
—
1.6e+00
7.8e-01
5.8e-01
cases:4.55%
controls:4.51%
cases:5.40%
controls:2.51%
cases:3.41%
controls:0.51%
—
—
cases:2.84%
controls:0.57%
cases:8.24%
controls:3.96%
cases:20.35%
controls:12.53%
16
158
336
3349
19
88
333
3419
12
18
340
3489
—
10
20
342
3487
29
138
323
3347
69
424
270
2959
Outpatient Visit
OP [9202]
OP [9202]
-4.1e-01
7.1e-02
3.9e-01
4.8e+00
5.0e-01
-3.2e-01
-4.1e-01
cases:47.73%
controls:57.94%
cases:49.72%
controls:47.93%
cases:18.47%
controls:13.34%
cases:38.64%
controls:0.51%
cases:22.44%
controls:14.94%
cases:46.02%
controls:54.03%
cases:75.81%
controls:82.53%
168
2032
184
1475
175
1681
177
1826
65
468
287
3039
136
18
216
3489
79
524
273
2983
162
1883
190
1602
257
2792
82
591
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
7.2e-01
1.3e+00
—
1.0e+50
2.1e+00
7.6e-01
3.6e-01
cases:28.13%
controls:15.97%
cases:19.60%
controls:6.50%
—
—
cases:48.86%
controls:0.00%
cases:5.97%
controls:0.77%
cases:13.64%
controls:6.86%
cases:32.15%
controls:24.77%
99
560
253
2947
69
228
283
3279
—
172
0
180
3507
21
27
331
3480
48
239
304
3246
109
838
230
2545
Orthodontics
143 [44777673]
143 [44777673]
8.4e-01
1.8e+00
—
—
—
1.7e+00
1.4e+00
cases:1.70%
controls:0.74%
cases:3.13%
controls:0.54%
—
—
—
—
—
—
cases:2.84%
controls:0.55%
cases:4.42%
controls:1.15%
6
26
346
3481
11
19
341
3488
—
—
—
10
19
342
3466
15
39
324
3344
Retained canine with obstruction in the upper jaw
K01.12 [2000502657]
K01.12 [2000502657]
—
—
1.0e+50
1.0e+50
1.0e+50
—
4.7e+00
—
—
—
—
cases:4.26%
controls:0.00%
cases:14.77%
controls:0.00%
cases:8.81%
controls:0.00%
—
—
cases:13.86%
controls:0.15%
—
—
15
0
337
3507
52
0
300
3507
31
0
321
3507
—
47
5
292
3378
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
-6.5e-02
1.2e+00
2.8e+00
—
—
7.3e-01
3.8e-01
cases:10.80%
controls:11.43%
cases:14.49%
controls:4.90%
cases:5.11%
controls:0.34%
—
—
—
—
cases:8.81%
controls:4.45%
cases:16.81%
controls:12.12%
38
401
314
3106
51
172
301
3335
18
12
334
3495
—
—
31
155
321
3330
57
410
282
2973
Separate planning of oral and dental treatment, standard
SAC01 [2001310283]
SAC01 [2001310283]
3.1e-01
1.8e+00
—
—
-1.0e+50
1.1e+00
1.8e+00
cases:6.53%
controls:4.88%
cases:8.52%
controls:1.57%
—
—
—
—
cases:0.00%
controls:0.14%
cases:4.83%
controls:1.69%
cases:12.68%
controls:2.42%
23
171
329
3336
30
55
322
3452
—
—
0
5
352
3502
17
59
335
3426
43
82
296
3301
Removal of fixed orthodontic appliance with at least 7 brackets
SJC50 [2001310435]
SJC50 [2001310435]
-1.6e-01
—
—
—
-1.0e+50
1.6e+00
2.6e+00
cases:1.70%
controls:2.00%
—
—
—
—
—
—
cases:0.00%
controls:0.29%
cases:9.09%
controls:1.89%
cases:38.94%
controls:4.61%
6
70
346
3437
—
—
—
0
10
352
3497
32
66
320
3419
132
156
207
3227
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
EB1HA [2001301913]
8.5e-01
2.4e+00
—
—
—
8.4e-01
2.9e-01
cases:23.30%
controls:11.46%
cases:28.98%
controls:3.56%
—
—
—
—
—
—
cases:7.67%
controls:3.47%
cases:15.93%
controls:12.44%
82
402
270
3105
102
125
250
3382
—
—
—
27
121
325
3364
54
421
285
2962
Other medical or dental certificate
WZA90 [2001310883]
WZA90 [2001310883]
7.2e-01
2.3e+00
—
—
—
1.0e+00
4.3e-01
cases:15.91%
controls:8.41%
cases:17.33%
controls:2.11%
—
—
—
—
—
—
cases:5.11%
controls:1.92%
cases:10.32%
controls:6.95%
56
295
296
3212
61
74
291
3433
—
—
—
18
67
334
3418
35
235
304
3148
Removal of fixed orthodontic appliance with at most 6 brackets
SJC40 [2001310434]
SJC40 [2001310434]
-6.7e-02
3.1e-01
—
—
—
1.8e+00
1.8e+00
cases:4.55%
controls:4.85%
cases:2.56%
controls:1.88%
—
—
—
—
—
—
cases:10.23%
controls:1.81%
cases:20.65%
controls:3.96%
16
170
336
3337
9
66
343
3441
—
—
—
36
63
316
3422
70
134
269
3249
Fitting of removable appliance incl. patient instructions
SJB00 [2001310422]
SJB00 [2001310422]
-1.4e-01
-3.3e-01
—
—
—
1.2e+00
2.2e+00
cases:3.98%
controls:4.53%
cases:1.70%
controls:2.37%
—
—
—
—
—
—
cases:8.52%
controls:2.81%
cases:34.51%
controls:5.47%
14
159
338
3348
6
83
346
3424
—
—
—
30
98
322
3387
117
185
222
3198
Radiological examination, not elsewhere classified
Z01.6 [45605096]
Z01.6 [45605096]
1.2e+00
3.2e+00
—
—
—
—
7.0e-01
cases:3.41%
controls:1.06%
cases:5.11%
controls:0.23%
—
—
—
—
—
—
—
—
cases:2.06%
controls:1.03%
12
37
340
3470
18
8
334
3499
—
—
—
—
7
35
332
3348
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
-3.1e-01
-2.6e-01
-1.6e-02
3.1e+00
-4.6e-01
-3.0e-01
-2.3e-01
cases:76.14%
controls:81.24%
cases:48.86%
controls:55.43%
cases:18.18%
controls:18.42%
cases:19.03%
controls:1.03%
cases:13.35%
controls:19.56%
cases:53.13%
controls:60.55%
cases:88.79%
controls:90.90%
268
2849
84
658
172
1944
180
1563
64
646
288
2861
67
36
285
3471
47
686
305
2821
187
2110
165
1375
301
3075
38
308
Basic examination of mouth
SAA02 [2001310275]
SAA02 [2001310275]
3.6e-02
3.2e-01
3.5e-02
3.0e+00
8.7e-01
-7.4e-02
-2.1e-03
cases:33.24%
controls:32.45%
cases:22.73%
controls:17.59%
cases:2.27%
controls:2.20%
cases:2.84%
controls:0.14%
cases:3.98%
controls:1.71%
cases:17.33%
controls:18.42%
cases:53.39%
controls:53.44%
117
1138
235
2369
80
617
272
2890
8
77
344
3430
10
5
342
3502
14
60
338
3447
61
642
291
2843
181
1808
158
1575
Intraoral radiographic dental examination
EB1AA [2001301903]
EB1AA [2001301903]
6.1e-01
1.7e+00
—
—
—
1.3e+00
4.9e-01
cases:9.66%
controls:5.47%
cases:10.80%
controls:2.22%
—
—
—
—
—
—
cases:7.39%
controls:2.12%
cases:12.98%
controls:8.37%
34
192
318
3315
38
78
314
3429
—
—
—
26
74
326
3411
44
283
295
3100
benzathine phenoxymethylpenicillin; oral
J01CE10 [21602850]
J01CE10 [21602850]
-9.0e-02
2.1e-01
—
1.0e+50
2.0e+00
9.3e-01
-7.8e-02
cases:11.65%
controls:12.60%
cases:3.69%
controls:3.02%
—
—
cases:12.78%
controls:0.00%
cases:2.56%
controls:0.37%
cases:6.25%
controls:2.55%
cases:15.34%
controls:16.38%
41
442
311
3065
13
106
339
3401
—
45
0
307
3507
9
13
343
3494
22
89
330
3396
52
554
287
2829
phenoxymethylpenicillin; oral
J01CE02 [21602842]
J01CE02 [21602842]
-9.0e-02
2.1e-01
—
1.0e+50
2.0e+00
9.3e-01
-7.8e-02
cases:11.65%
controls:12.60%
cases:3.69%
controls:3.02%
—
—
cases:12.78%
controls:0.00%
cases:2.56%
controls:0.37%
cases:6.25%
controls:2.55%
cases:15.34%
controls:16.38%
41
442
311
3065
13
106
339
3401
—
45
0
307
3507
9
13
343
3494
22
89
330
3396
52
554
287
2829
Cephalometry with X-ray
EB1MA [2001301916]
EB1MA [2001301916]
7.7e-01
2.1e+00
—
—
—
-1.0e+50
3.3e-01
cases:11.36%
controls:5.62%
cases:10.51%
controls:1.40%
—
—
—
—
—
—
cases:0.00%
controls:0.83%
cases:2.65%
controls:1.92%
40
197
312
3310
37
49
315
3458
—
—
—
0
29
352
3456
9
65
330
3318
Oral Surgery
19 [38004464]
19 [38004464]
—
2.8e+00
—
1.0e+50
—
1.6e+00
5.4e-01
—
—
cases:5.11%
controls:0.34%
—
—
cases:5.68%
controls:0.00%
—
—
cases:1.70%
controls:0.34%
cases:2.36%
controls:1.39%
—
18
12
334
3495
—
20
0
332
3507
—
6
12
346
3473
8
47
331
3336
Clinical photography of mouth and teeth
SBB00 [2001310298]
SBB00 [2001310298]
3.0e-01
1.5e+00
—
—
—
6.5e-01
1.1e+00
cases:4.83%
controls:3.62%
cases:5.97%
controls:1.43%
—
—
—
—
—
—
cases:2.56%
controls:1.35%
cases:12.98%
controls:4.52%
17
127
335
3380
21
50
331
3457
—
—
—
9
47
343
3438
44
153
295
3230
Removal of sutures from oral mucosa
SXB00 [2001310580]
SXB00 [2001310580]
—
—
—
—
—
2.6e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:2.27%
controls:0.17%
cases:1.77%
controls:0.44%
—
—
—
—
—
8
6
344
3479
6
15
333
3368
Orthodontic finishing
SJE90 [2001310447]
SJE90 [2001310447]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.24%
controls:0.27%
—
—
—
—
—
—
11
9
328
3374
Extended examination of mouth
SAA03 [2001310276]
SAA03 [2001310276]
1.4e-01
1.1e+00
1.3e+00
—
7.7e-01
-4.5e-02
3.1e-01
cases:25.28%
controls:22.75%
cases:30.11%
controls:12.09%
cases:4.55%
controls:1.25%
—
—
cases:2.56%
controls:1.20%
cases:12.22%
controls:12.71%
cases:38.05%
controls:30.98%
89
798
263
2709
106
424
246
3083
16
44
336
3463
—
9
42
343
3465
43
443
309
3042
129
1048
210
2335
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
WZC10 [2001310887]
1.2e+00
2.3e+00
—
—
—
—
1.2e+00
cases:2.84%
controls:0.86%
cases:3.69%
controls:0.37%
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.53%
10
30
342
3477
13
13
339
3494
—
—
—
—
6
18
333
3365
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-6.6e-01
-8.4e-01
—
—
—
1.4e+00
3.0e+00
cases:15.91%
controls:26.86%
cases:4.55%
controls:9.89%
—
—
—
—
—
—
cases:2.27%
controls:0.57%
cases:11.50%
controls:0.65%
56
942
296
2565
16
347
336
3160
—
—
—
8
20
344
3465
39
22
300
3361
Operative extraction of tooth
EBA10 [2001301925]
EBA10 [2001301925]
9.2e-01
—
—
1.0e+50
—
2.3e+00
4.4e-01
cases:1.42%
controls:0.57%
—
—
—
—
cases:5.11%
controls:0.00%
—
—
cases:1.70%
controls:0.17%
cases:2.95%
controls:1.92%
5
20
347
3487
—
—
18
0
334
3507
—
6
6
346
3479
10
65
329
3318
Demanding operative extraction of tooth
EBA12 [2001301926]
EBA12 [2001301926]
—
-1.0e+50
—
1.0e+50
—
—
2.1e+00
—
—
cases:0.00%
controls:0.14%
—
—
cases:1.70%
controls:0.00%
—
—
—
—
cases:2.65%
controls:0.33%
—
0
5
352
3502
—
6
0
346
3507
—
—
9
11
330
3372
Extraction of tooth
EBA00 [2001301923]
EBA00 [2001301923]
7.2e-01
1.3e+00
—
1.0e+50
—
4.9e-01
4.5e-02
cases:23.58%
controls:13.03%
cases:14.77%
controls:4.39%
—
—
cases:14.20%
controls:0.00%
—
—
cases:5.11%
controls:3.19%
cases:8.26%
controls:7.92%
83
457
269
3050
52
154
300
3353
—
50
0
302
3507
—
18
111
334
3374
28
268
311
3115
Extraoral traction arrangements and operation instruction, removable appliance
SJB30 [2001310424]
SJB30 [2001310424]
4.0e-01
2.0e+00
—
—
—
—
1.0e+00
cases:3.13%
controls:2.11%
cases:2.56%
controls:0.34%
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.65%
11
74
341
3433
9
12
343
3495
—
—
—
—
6
22
333
3361
Other disturbance in the tooth eruption
K00.68 [2000502648]
K00.68 [2000502648]
8.4e-01
2.0e+00
—
—
—
1.9e+00
—
cases:3.13%
controls:1.37%
cases:3.13%
controls:0.43%
—
—
—
—
—
—
cases:1.70%
controls:0.26%
—
—
11
48
341
3459
11
15
341
3492
—
—
—
6
9
346
3476
—
Pulp capping
SGC10 [2001310393]
SGC10 [2001310393]
2.0e+00
—
—
—
—
—
3.8e-01
cases:2.84%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:2.95%
controls:2.04%
10
14
342
3493
—
—
—
—
—
10
69
329
3314
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
2.0e+00
—
—
—
—
—
—
cases:1.99%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
7
10
345
3497
—
—
—
—
—
—
Telephone prescription or other care instructions
WZB00 [2001310884]
WZB00 [2001310884]
7.2e-01
1.8e+00
—
1.0e+50
—
1.4e+00
2.4e-02
cases:3.13%
controls:1.54%
cases:3.13%
controls:0.51%
—
—
cases:5.40%
controls:0.00%
—
—
cases:1.99%
controls:0.52%
cases:4.72%
controls:4.61%
11
54
341
3453
11
18
341
3489
—
19
0
333
3507
—
7
18
345
3467
16
156
323
3227
Other therapy enhancing rehabilitation
R4160 [2001310240]
R4160 [2001310240]
1.7e+00
—
-1.0e+50
—
—
—
—
cases:2.27%
controls:0.43%
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
8
15
344
3492
—
0
6
352
3501
—
—
—
—
FEV1
20150-9 [3024653]
20150-9 [3024653]
6.7e-01
—
—
—
—
—
1.6e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:3.24%
controls:0.65%
7
36
345
3471
—
—
—
—
—
11
22
328
3361
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
6.7e-01
—
—
—
—
—
1.6e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:3.24%
controls:0.65%
7
36
345
3471
—
—
—
—
—
11
22
328
3361
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
6.7e-01
—
—
—
—
—
1.6e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:3.24%
controls:0.65%
7
36
345
3471
—
—
—
—
—
11
22
328
3361
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
6.7e-01
—
—
—
—
—
1.5e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:2.95%
controls:0.65%
7
36
345
3471
—
—
—
—
—
10
22
329
3361
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
6.7e-01
—
—
—
—
—
1.5e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:2.95%
controls:0.65%
7
36
345
3471
—
—
—
—
—
10
22
329
3361
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
6.7e-01
—
—
—
—
—
1.5e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:2.95%
controls:0.65%
7
36
345
3471
—
—
—
—
—
10
22
329
3361
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
6.7e-01
—
—
—
—
—
1.5e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:2.95%
controls:0.65%
7
36
345
3471
—
—
—
—
—
10
22
329
3361
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
6.7e-01
—
—
—
—
—
1.5e+00
cases:1.99%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:2.95%
controls:0.65%
7
36
345
3471
—
—
—
—
—
10
22
329
3361
Fitting of removable appliance incl. patient instructions, demanding
SJB10 [2001310423]
SJB10 [2001310423]
-1.3e-01
1.7e-01
—
—
—
4.4e-01
1.5e+00
cases:1.99%
controls:2.25%
cases:1.42%
controls:1.20%
—
—
—
—
—
—
cases:1.42%
controls:0.92%
cases:4.72%
controls:1.09%
7
79
345
3428
5
42
347
3465
—
—
—
5
32
347
3453
16
37
323
3346
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
1.1e+00
—
—
—
-1.0e+50
—
1.5e+00
cases:3.13%
controls:1.08%
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
cases:2.95%
controls:0.68%
11
38
341
3469
—
—
—
0
8
352
3499
—
10
23
329
3360
Adjustment and grinding of removable appliance
SJB60 [2001310425]
SJB60 [2001310425]
1.9e-01
-2.3e-01
—
—
-1.0e+50
8.3e-02
1.5e+00
cases:5.11%
controls:4.28%
cases:1.70%
controls:2.14%
—
—
—
—
cases:0.00%
controls:0.20%
cases:2.27%
controls:2.09%
cases:11.21%
controls:2.78%
18
150
334
3357
6
75
346
3432
—
—
0
7
352
3500
8
73
344
3412
38
94
301
3289
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
19550-3 [3028707]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.24%
controls:0.80%
—
—
—
—
—
—
11
27
328
3356
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.13%
controls:1.03%
—
—
—
—
—
—
14
35
325
3348
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
1.3e+00
1.5e+00
—
—
—
—
7.3e-01
cases:4.83%
controls:1.43%
cases:1.70%
controls:0.37%
—
—
—
—
—
—
—
—
cases:2.06%
controls:1.01%
17
50
335
3457
6
13
346
3494
—
—
—
—
7
34
332
3349
Retrognaty, mandibular
K07.13 [2000502762]
K07.13 [2000502762]
4.2e-01
9.0e-01
—
—
—
—
1.2e+00
cases:2.27%
controls:1.51%
cases:2.27%
controls:0.94%
—
—
—
—
—
—
—
—
cases:3.83%
controls:1.18%
8
53
344
3454
8
33
344
3474
—
—
—
—
13
40
326
3343
Hypodontia
K00.00 [2000502614]
K00.00 [2000502614]
1.0e-01
7.7e-01
—
—
—
1.1e+00
1.2e+00
cases:1.70%
controls:1.54%
cases:2.84%
controls:1.34%
—
—
—
—
—
—
cases:3.13%
controls:1.06%
cases:6.78%
controls:2.22%
6
54
346
3453
10
47
342
3460
—
—
—
11
37
341
3448
23
75
316
3308
Other childhood emotional disorders
F93.89 [2000502046]
F93.89 [2000502046]
—
—
—
—
—
—
1.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.83%
controls:1.24%
—
—
—
—
—
—
13
42
326
3341
Surface analgesia on skin or mucosa
WX105 [2001310765]
WX105 [2001310765]
3.2e-01
1.1e+00
-1.0e+50
1.0e+50
1.7e+00
5.6e-01
7.4e-01
cases:7.10%
controls:5.25%
cases:5.68%
controls:1.88%
cases:0.00%
controls:0.20%
cases:3.69%
controls:0.00%
cases:1.42%
controls:0.26%
cases:1.99%
controls:1.15%
cases:4.42%
controls:2.16%
25
184
327
3323
20
66
332
3441
0
7
352
3500
13
0
339
3507
5
9
347
3498
7
40
345
3445
15
73
324
3310
Anomalies of dental arch relationship
K07.25 [2000502771]
K07.25 [2000502771]
6.2e-01
1.1e+00
—
—
—
7.5e-01
6.5e-01
cases:5.97%
controls:3.31%
cases:4.55%
controls:1.51%
—
—
—
—
—
—
cases:3.69%
controls:1.78%
cases:6.19%
controls:3.34%
21
116
331
3391
16
53
336
3454
—
—
—
13
62
339
3423
21
113
318
3270
Assessment of need for orthodontic treatment
SJF01 [2001310449]
SJF01 [2001310449]
2.5e-01
1.1e+00
—
—
—
—
—
cases:7.67%
controls:6.10%
cases:3.69%
controls:1.23%
—
—
—
—
—
—
—
—
—
—
27
214
325
3293
13
43
339
3464
—
—
—
—
—
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
-4.1e-01
4.0e-01
—
—
—
4.1e-01
1.1e+00
cases:1.99%
controls:2.97%
cases:2.27%
controls:1.54%
—
—
—
—
—
—
cases:1.42%
controls:0.95%
cases:5.60%
controls:1.92%
7
104
345
3403
8
54
344
3453
—
—
—
5
33
347
3452
19
65
320
3318
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
-2.7e-01
3.8e-01
—
—
—
4.1e-01
1.1e+00
cases:2.27%
controls:2.97%
cases:2.27%
controls:1.57%
—
—
—
—
—
—
cases:1.42%
controls:0.95%
cases:5.90%
controls:2.07%
8
104
344
3403
8
55
344
3452
—
—
—
5
33
347
3452
20
70
319
3313
Audiometric test
21727005 [4071702]
21727005 [4071702]
7.8e-01
—
—
—
—
—
1.1e+00
cases:3.41%
controls:1.60%
—
—
—
—
—
—
—
—
—
—
cases:5.01%
controls:1.77%
12
56
340
3451
—
—
—
—
—
17
60
322
3323
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
-2.1e-01
4.2e-01
—
—
—
—
1.0e+00
cases:2.27%
controls:2.79%
cases:2.27%
controls:1.51%
—
—
—
—
—
—
—
—
cases:5.01%
controls:1.86%
8
98
344
3409
8
53
344
3454
—
—
—
—
17
63
322
3320
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
-2.9e-01
3.6e-01
—
—
-1.0e+50
3.2e-01
1.0e+00
cases:2.27%
controls:3.02%
cases:2.27%
controls:1.60%
—
—
—
—
cases:0.00%
controls:0.14%
cases:1.42%
controls:1.03%
cases:5.90%
controls:2.22%
8
106
344
3401
8
56
344
3451
—
—
0
5
352
3502
5
36
347
3449
20
75
319
3308
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
-2.9e-01
3.6e-01
—
—
-1.0e+50
2.9e-01
1.0e+00
cases:2.27%
controls:3.02%
cases:2.27%
controls:1.60%
—
—
—
—
cases:0.00%
controls:0.14%
cases:1.42%
controls:1.06%
cases:5.90%
controls:2.25%
8
106
344
3401
8
56
344
3451
—
—
0
5
352
3502
5
37
347
3448
20
76
319
3307
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
-2.9e-01
3.8e-01
—
—
-1.0e+50
3.2e-01
1.0e+00
cases:2.27%
controls:3.02%
cases:2.27%
controls:1.57%
—
—
—
—
cases:0.00%
controls:0.14%
cases:1.42%
controls:1.03%
cases:5.90%
controls:2.25%
8
106
344
3401
8
55
344
3452
—
—
0
5
352
3502
5
36
347
3449
20
76
319
3307
Knee symptom/complaint
L15 [2002000639]
L15 [2002000639]
-6.6e-01
3.1e-02
-1.0e+50
—
—
5.3e-01
9.9e-01
cases:1.70%
controls:3.25%
cases:1.70%
controls:1.65%
cases:0.00%
controls:0.26%
—
—
—
—
cases:2.56%
controls:1.52%
cases:10.03%
controls:3.99%
6
114
346
3393
6
58
346
3449
0
9
352
3498
—
—
9
53
343
3432
34
135
305
3248
Teeth/gum symptom/complaint
D19 [2002000318]
D19 [2002000318]
-6.2e-02
5.7e-01
1.5e+00
—
1.3e+00
9.6e-01
5.0e-01
cases:3.98%
controls:4.22%
cases:4.55%
controls:2.62%
cases:2.27%
controls:0.51%
—
—
cases:1.70%
controls:0.48%
cases:7.10%
controls:2.84%
cases:13.57%
controls:8.72%
14
148
338
3359
16
92
336
3415
8
18
344
3489
—
6
17
346
3490
25
99
327
3386
46
295
293
3088
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
14683-7 [3009508]
3.1e-01
2.7e-01
—
—
—
5.8e-01
9.3e-01
cases:2.56%
controls:1.88%
cases:1.70%
controls:1.31%
—
—
—
—
—
—
cases:2.27%
controls:1.29%
cases:6.49%
controls:2.66%
9
66
343
3441
6
46
346
3461
—
—
—
8
45
344
3440
22
90
317
3293
Deep bite
K07.23 [2000502769]
K07.23 [2000502769]
-4.4e-01
4.0e-01
6.2e-01
—
1.0e+00
3.9e-01
8.6e-01
cases:3.69%
controls:5.65%
cases:5.97%
controls:4.08%
cases:1.42%
controls:0.77%
—
—
cases:2.27%
controls:0.83%
cases:5.97%
controls:4.13%
cases:10.91%
controls:4.91%
13
198
339
3309
21
143
331
3364
5
27
347
3480
—
8
29
344
3478
21
144
331
3341
37
166
302
3217
Feeling ill
A05 [2002000146]
A05 [2002000146]
-1.2e-02
9.0e-02
—
—
—
-3.4e-01
6.0e-01
cases:3.41%
controls:3.45%
cases:2.27%
controls:2.08%
—
—
—
—
—
—
cases:1.99%
controls:2.78%
cases:13.27%
controls:7.77%
12
121
340
3386
8
73
344
3434
—
—
—
7
97
345
3388
45
263
294
3120
Vaginal discharge
X14 [2002001299]
X14 [2002001299]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
—
—
—
—
—
—
4.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.36%
controls:1.51%
—
—
—
—
—
—
8
51
331
3332
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
0
13
352
3494
—
—
—
—
—
Check up of cardiac pacemaker
XFP20 [2001303367]
XFP20 [2001303367]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Genetic counselling
Z31.5 [45590715]
Z31.5 [45590715]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.44%
—
—
—
—
—
—
0
15
339
3368
Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]
QBE10 [2001309853]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
0
6
352
3501
—
—
—
—
—
0
6
339
3377
UVB narrow spectrum light therapy
WXQ27 [2001310161]
WXQ27 [2001310161]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
0
5
352
3502
—
—
—
—
—
0
9
339
3374
triamcinolone and antiseptics
D07BB03 [21602150]
D07BB03 [21602150]
2.0e-01
-1.0e+50
—
—
—
5.8e-01
2.6e-01
cases:3.13%
controls:2.57%
cases:0.00%
controls:0.54%
—
—
—
—
—
—
cases:1.42%
controls:0.80%
cases:4.72%
controls:3.69%
11
90
341
3417
0
19
352
3488
—
—
—
5
28
347
3457
16
125
323
3258
Repair of umbilical hernia
JAF10 [2001304441]
JAF10 [2001304441]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Pauciarticular juvenile arthritis
M08.4 [45582020]
M08.4 [45582020]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
0
16
352
3469
—
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
-3.7e-01
3.3e-01
—
—
—
5.4e-01
-1.0e-01
cases:1.99%
controls:2.85%
cases:1.70%
controls:1.23%
—
—
—
—
—
—
cases:1.70%
controls:1.00%
cases:3.54%
controls:3.90%
7
100
345
3407
6
43
346
3464
—
—
—
6
35
346
3450
12
132
327
3251
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
A04AA02 [21600494]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
0
9
352
3498
0
6
352
3501
—
—
—
0
7
352
3478
—
Hyperemia of pulp
K04.00 [2000502702]
K04.00 [2000502702]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
0
11
339
3372
Colonoscopy Study observation
28023-0 [3022145]
28023-0 [3022145]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
0
6
352
3501
—
—
—
—
—
Fall involving playground equipment
W09 [45756249]
W09 [45756249]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
352
3499
—
—
—
—
—
—
Thyroglobulin [Mass/volume] in Serum or Plasma
3013-0 [3036535]
3013-0 [3036535]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
0
8
339
3375
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]
21613-5 [3006093]
—
—
—
—
—
—
9.7e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.54%
controls:3.22%
—
—
—
—
—
—
12
109
327
3274
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
2.8e-01
3.1e-02
—
—
-1.0e+50
6.0e-01
1.3e-01
cases:2.84%
controls:2.17%
cases:1.70%
controls:1.65%
—
—
—
—
cases:0.00%
controls:0.51%
cases:2.27%
controls:1.26%
cases:3.83%
controls:3.40%
10
76
342
3431
6
58
346
3449
—
—
0
18
352
3489
8
44
344
3441
13
115
326
3268
Laboratory test
15220000 [4034850]
15220000 [4034850]
—
—
—
—
—
—
9.2e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.36%
controls:2.16%
—
—
—
—
—
—
8
73
331
3310
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
D42.9 [45542703]
D42.9 [45542703]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
352
3494
—
—
—
—
—
—
Evaluation of patient with eating disorder
IBZ05 [2001304079]
IBZ05 [2001304079]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.68%
—
—
—
—
—
0
11
352
3474
0
23
339
3360
Other conjunctival vascular disorders and cysts
H11.4 [45600856]
H11.4 [45600856]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
0
11
339
3372
Karyotype 45,X
Q96.0 [45548941]
Q96.0 [45548941]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
0
5
352
3502
—
—
—
—
—
Epilepsy
G40 [45595935]
G40 [45595935]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
0
7
352
3500
—
—
—
0
12
352
3473
—
Anorexia nervosa/bulimia
P86 [2002000878]
P86 [2002000878]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
0
6
352
3479
—
prochlorperazine; oral, parenteral, rectal
N05AB04 [21604503]
N05AB04 [21604503]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
352
3497
—
—
—
—
—
—
Unspecified viral infection characterized by skin and mucous membrane lesions
B09 [45532866]
B09 [45532866]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Oxygen content in Venous blood
19220-3 [3011648]
19220-3 [3011648]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
permethrin
P03AC04 [21604984]
P03AC04 [21604984]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
0
9
339
3374
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
-2.4e-01
3.3e-01
—
—
—
4.1e-01
9.9e-02
cases:4.83%
controls:6.07%
cases:4.83%
controls:3.54%
—
—
—
—
—
—
cases:4.83%
controls:3.24%
cases:18.29%
controls:16.85%
17
213
335
3294
17
124
335
3383
—
—
—
17
113
335
3372
62
570
277
2813
Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
33942-4 [3046896]
33942-4 [3046896]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
14647-2 [3019900]
3.4e-01
6.7e-01
—
—
—
2.9e-01
-1.0e-01
cases:3.69%
controls:2.65%
cases:3.13%
controls:1.63%
—
—
—
—
—
—
cases:2.56%
controls:1.92%
cases:7.08%
controls:7.77%
13
93
339
3414
11
57
341
3450
—
—
—
9
67
343
3418
24
263
315
3120
Exophoria
H50.52 [2000502357]
H50.52 [2000502357]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
—
—
0
19
352
3488
—
—
—
—
—
—
Cellulitis
L03 [45591621]
L03 [45591621]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Pelvis X-ray examination
NE1AA [2001307792]
NE1AA [2001307792]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Adjustment and management of infusion pump
Z45.1 [45571356]
Z45.1 [45571356]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Gingivitis (chronic) ulcerative
K05.19 [2000502722]
K05.19 [2000502722]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
0
11
339
3372
Extensive neurological examination
SPAT1050 [2001700151]
SPAT1050 [2001700151]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.38%
—
—
—
—
—
0
6
352
3479
0
13
339
3370
Sprain and strain of toe(s)
S93.5 [45555651]
S93.5 [45555651]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
0
9
339
3374
Influenza with other respiratory manifestations, seasonal influenza virus identified
J10.1 [45601120]
J10.1 [45601120]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Phadiatop IgE Ab [Units/volume] in Serum
7599-4 [3025443]
7599-4 [3025443]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Contusion of other and unspecified parts of foot
S90.3 [45584475]
S90.3 [45584475]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
0
6
352
3479
—
Glucose [Moles/volume] in Capillary blood
51596-5 [3040151]
51596-5 [3040151]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
K52.9 [45572215]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
0
9
339
3374
Guidance regarding sleep disorders
SPAT1051 [2001700152]
SPAT1051 [2001700152]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
0
26
339
3357
Planned therapy visit for psychiatric disease
W0A12 [2001310894]
W0A12 [2001310894]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
0
5
352
3502
0
5
352
3502
—
—
—
—
0
11
339
3372
Acute lymphoblastic leukaemia [ALL]
C91.0 [45537873]
C91.0 [45537873]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:1.03%
—
—
cases:0.00%
controls:0.77%
—
—
—
—
—
—
0
36
352
3471
—
0
27
352
3480
—
—
Assessment of need for rehabilitation and/or rehabilitation plan
SPAT1220 [2001700321]
SPAT1220 [2001700321]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
cyproterone and estrogen
G03HB01 [21602617]
G03HB01 [21602617]
—
—
—
—
—
—
1.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:2.39%
—
—
—
—
—
—
9
81
330
3302
Need for immunization against unspecified infectious disease
Z26.9 [45590712]
Z26.9 [45590712]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
0
7
352
3478
—
Very extensive written report from radiologist
XX1ZW [2001311009]
XX1ZW [2001311009]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
Fluoride application or other respective small prophylactic procedure
SCC01 [2001310310]
SCC01 [2001310310]
3.4e-01
1.1e+00
—
—
—
—
—
cases:2.27%
controls:1.63%
cases:2.84%
controls:0.94%
—
—
—
—
—
—
—
—
—
—
8
57
344
3450
10
33
342
3474
—
—
—
—
—
Fracture of lower leg, part unspecified
S82.9 [45584373]
S82.9 [45584373]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
0
11
352
3496
—
—
—
—
—
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
-1.3e-01
4.1e-01
—
—
—
3.9e-01
1.0e-01
cases:3.13%
controls:3.54%
cases:1.70%
controls:1.14%
—
—
—
—
—
—
cases:2.27%
controls:1.55%
cases:11.50%
controls:10.49%
11
124
341
3383
6
40
346
3467
—
—
—
8
54
344
3431
39
355
300
3028
Naevus/mole
S82 [2002001046]
S82 [2002001046]
—
—
—
—
—
-1.0e+50
3.1e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.40%
cases:2.36%
controls:1.74%
—
—
—
—
—
0
14
352
3471
8
59
331
3324
promethazine, combinations
R06AD52 [21603489]
R06AD52 [21603489]
2.1e-01
—
—
—
—
-1.0e+50
—
cases:2.27%
controls:1.85%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
8
65
344
3442
—
—
—
—
0
11
352
3474
—
Suture of gingiva
ECB00 [2001301968]
ECB00 [2001301968]
—
—
—
1.0e+50
—
—
-1.0e+50
—
—
—
—
—
—
cases:1.70%
controls:0.00%
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
6
0
346
3507
—
—
0
12
339
3371
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
Simple partial seizures
G40.10 [2000502135]
G40.10 [2000502135]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
352
3501
—
—
—
—
—
—
pertussis, purified antigen, combinations with toxoids
J07AJ52 [21601308]
J07AJ52 [21601308]
—
4.7e-01
—
—
—
-3.0e-01
1.8e-01
—
—
cases:2.27%
controls:1.43%
—
—
—
—
—
—
cases:2.27%
controls:3.04%
cases:16.52%
controls:14.13%
—
8
50
344
3457
—
—
—
8
106
344
3379
56
478
283
2905
Sprain/strain of ankle
L77 [2002000696]
L77 [2002000696]
—
—
—
—
—
-1.0e+50
3.3e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.40%
cases:1.47%
controls:1.06%
—
—
—
—
—
0
14
352
3471
5
36
334
3347
Obstruction of Eustachian tube
H68.1 [45586536]
H68.1 [45586536]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18243-6 [3002823]
18243-6 [3002823]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
econazole; vaginal
G01AF05 [21602395]
G01AF05 [21602395]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
Appearance of Cerebral spinal fluid
10333-3 [3023410]
10333-3 [3023410]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
352
3497
—
—
—
—
—
—
Eating disorder, unspecified
F50.9 [45547713]
F50.9 [45547713]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
Open wound of ear
S01.3 [45553789]
S01.3 [45553789]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
loratadine; oral
R06AX13 [21603514]
R06AX13 [21603514]
3.1e-02
—
—
—
—
—
-2.6e-01
cases:2.56%
controls:2.48%
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:2.28%
9
87
343
3420
—
—
—
—
—
6
77
333
3306
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
0
6
352
3501
0
5
352
3502
—
—
—
—
—
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
4.2e-01
—
-1.0e+50
—
—
7.2e-01
1.1e-01
cases:1.42%
controls:0.94%
—
—
cases:0.00%
controls:0.14%
—
—
—
—
cases:1.99%
controls:0.98%
cases:2.65%
controls:2.39%
5
33
347
3474
—
0
5
352
3502
—
—
7
34
345
3451
9
81
330
3302
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
1.8e+00
—
—
—
—
—
1.2e+00
cases:1.42%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.44%
5
8
347
3499
—
—
—
—
—
5
15
334
3368
Gynecological ultrasound examination as part of clinical examination
LX1AE [2001306815]
LX1AE [2001306815]
—
—
—
—
—
-1.0e+50
1.3e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:1.47%
controls:1.30%
—
—
—
—
—
0
6
352
3479
5
44
334
3339
Ear microscopy
UDC00 [2001301558]
UDC00 [2001301558]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.54%
—
—
—
—
—
—
cases:0.00%
controls:0.43%
—
—
—
0
19
352
3488
—
—
—
0
15
352
3470
—
tizanidine; oral
M03BX02 [21604116]
M03BX02 [21604116]
—
-1.0e+50
—
—
—
—
1.5e-02
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.77%
controls:1.74%
—
0
5
352
3502
—
—
—
—
6
59
333
3324
Mouth breathing
R06.5 [45573006]
R06.5 [45573006]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
9
352
3498
—
—
—
—
—
Other lichen planus
L43.8 [45577038]
L43.8 [45577038]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Juvenile arthritis, unspecified
M08.9 [45596451]
M08.9 [45596451]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
ZXE02 [2001311396]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.36%
controls:0.56%
—
—
—
—
—
—
8
19
331
3364
Functional endoscopic opening of maxillary antrum
DMB20 [2001301780]
DMB20 [2001301780]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
352
3500
—
—
—
—
—
—
Benign tumor of the ovary (ovary), other specified histology
D27.98 [2000501305]
D27.98 [2000501305]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.15%
0
5
352
3502
0
5
352
3502
—
—
—
0
5
352
3480
0
5
339
3378
Opiates [Presence] in Urine
3879-4 [3027008]
3879-4 [3027008]
—
—
—
—
—
—
8.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.13%
controls:1.74%
—
—
—
—
—
—
14
59
325
3324
Psychiatric pharmacotherapy plan, not specified
IFA01 [2001304251]
IFA01 [2001304251]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.29%
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
0
10
352
3497
0
10
352
3497
—
—
—
—
—
Other misshapen ear
Q17.3 [45568055]
Q17.3 [45568055]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
—
—
0
15
352
3492
—
—
—
—
—
—
azelaic acid; ointment
D10AX03 [21602314]
D10AX03 [21602314]
—
-1.0e+50
-1.0e+50
—
-1.0e+50
—
4.3e-01
—
—
cases:0.00%
controls:0.66%
cases:0.00%
controls:0.20%
—
—
cases:0.00%
controls:0.23%
—
—
cases:5.31%
controls:3.52%
—
0
23
352
3484
0
7
352
3500
—
0
8
352
3499
—
18
119
321
3264
Idiopathic urticaria
L50.1 [45552982]
L50.1 [45552982]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Congenital absence, atresia and stricture of auditory canal (external)
Q16.1 [45592361]
Q16.1 [45592361]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
352
3497
—
—
—
—
—
—
Amenorrhoea, unspecified
N91.2 [45592157]
N91.2 [45592157]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.30%
—
—
—
—
—
—
0
10
339
3373
hydrocortisone and antiinfectives
S03CA04 [21605208]
S03CA04 [21605208]
1.0e-01
—
—
—
—
—
-5.3e-02
cases:2.56%
controls:2.31%
—
—
—
—
—
—
—
—
—
—
cases:3.54%
controls:3.72%
9
81
343
3426
—
—
—
—
—
12
126
327
3257
Allergic rhinitis, unspecified
J30.4 [45548110]
J30.4 [45548110]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.74%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
0
26
352
3481
—
—
—
—
—
0
12
339
3371
Intermittent esotropy
H50.30 [2000502352]
H50.30 [2000502352]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
352
3501
—
—
—
—
—
—
lenograstim; parenteral
L03AA10 [21603854]
L03AA10 [21603854]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.40%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
0
14
352
3493
0
5
352
3502
—
—
—
—
—
Hypopituitarism after medical therapy
E89.32 [2000501558]
E89.32 [2000501558]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.33%
—
0
5
352
3502
—
—
—
0
9
352
3476
0
11
339
3372
Structured assessment of psychoactive substance / tobacco use
SPAT1273 [2001700374]
SPAT1273 [2001700374]
—
—
—
—
—
—
5.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:1.60%
—
—
—
—
—
—
9
54
330
3329
Erysipelas
A46 [45561706]
A46 [45561706]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
352
3501
—
—
—
—
—
—
Migraine with aura [classical migraine]
G43.1 [45562086]
G43.1 [45562086]
—
—
-1.0e+50
—
—
—
-7.7e-01
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:1.47%
controls:3.13%
—
—
0
7
352
3500
—
—
—
5
106
334
3277
Pain general/multiple sites
A01 [2002000142]
A01 [2002000142]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
352
3496
—
—
—
—
—
—
Ocular fundus photography for diabetic retinopathy screening
CL2S4 [2001301465]
CL2S4 [2001301465]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
352
3496
—
—
—
—
—
—
susoctocog alfa
B02BD14 [45893482]
B02BD14 [45893482]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.18%
0
6
352
3501
0
5
352
3502
—
—
—
0
6
352
3479
0
6
339
3377
drospirenone and ethinylestradiol
G03AA12 [21602485]
G03AA12 [21602485]
—
-1.0e+50
-1.0e+50
—
-1.0e+50
—
9.1e-02
—
—
cases:0.00%
controls:0.43%
cases:0.00%
controls:0.14%
—
—
cases:0.00%
controls:0.26%
—
—
cases:8.26%
controls:7.60%
—
0
15
352
3492
0
5
352
3502
—
0
9
352
3498
—
28
257
311
3126
Personal history of leukaemia
Z85.6 [45609980]
Z85.6 [45609980]
—
—
-1.0e+50
—
-1.0e+50
—
-1.0e+50
—
—
—
—
cases:0.00%
controls:0.17%
—
—
cases:0.00%
controls:0.20%
—
—
cases:0.00%
controls:1.80%
—
—
0
6
352
3501
—
0
7
352
3500
—
0
61
339
3322
Redundant prepuce, phimosis and paraphimosis
N47 [45596870]
N47 [45596870]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
0
10
352
3497
—
—
—
—
0
8
352
3477
—
Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
69930-6 [42868421]
69930-6 [42868421]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Extraoral traction appliance arrangement incl. patient instructions
SJC20 [2001310433]
SJC20 [2001310433]
3.2e-01
—
—
—
—
—
—
cases:1.99%
controls:1.45%
—
—
—
—
—
—
—
—
—
—
—
—
7
51
345
3456
—
—
—
—
—
—
Gastroscopy
UJD02 [2001304787]
UJD02 [2001304787]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Flail joint
M25.2 [45567527]
M25.2 [45567527]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
betamethasone
C05AA05 [21601610]
C05AA05 [21601610]
—
—
—
—
—
—
-1.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.54%
controls:4.02%
—
—
—
—
—
—
12
136
327
3247
Glucose tolerance test outside reference range
274858002 [440216]
274858002 [440216]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:0.00%
controls:0.20%
cases:0.00%
controls:0.18%
0
9
352
3498
0
7
352
3500
—
—
—
0
7
352
3478
0
6
339
3377
Endomysium IgG Ab [Titer] in Serum
49726-3 [3032773]
49726-3 [3032773]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.40%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
0
14
352
3493
0
5
352
3502
—
—
—
0
10
352
3475
—
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
2.7e-02
4.7e-01
3.6e-01
—
4.8e-01
5.3e-01
1.4e-01
cases:5.97%
controls:5.82%
cases:5.68%
controls:3.62%
cases:1.42%
controls:1.00%
—
—
cases:1.42%
controls:0.88%
cases:5.11%
controls:3.07%
cases:12.39%
controls:10.94%
21
204
331
3303
20
127
332
3380
5
35
347
3472
—
5
31
347
3476
18
107
334
3378
42
370
297
3013
Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
14688-6 [3016616]
14688-6 [3016616]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.35%
—
—
—
—
—
—
0
12
339
3371
Other psychiatric treatment contact
IGY99 [2001304323]
IGY99 [2001304323]
—
—
—
—
—
—
8.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.36%
controls:1.01%
—
—
—
—
—
—
8
34
331
3349
Injury of eye and orbit, unspecified
S05.9 [45577888]
S05.9 [45577888]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
0
8
339
3375
Abnormal weight loss
R63.4 [45568144]
R63.4 [45568144]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
-6.0e-02
2.2e-01
3.5e-02
—
8.5e-02
6.6e-02
2.5e-02
cases:9.38%
controls:9.89%
cases:9.38%
controls:7.64%
cases:2.27%
controls:2.20%
—
—
cases:1.70%
controls:1.57%
cases:8.81%
controls:8.29%
cases:33.92%
controls:33.37%
33
347
319
3160
33
268
319
3239
8
77
344
3430
—
6
55
346
3452
31
289
321
3196
115
1129
224
2254
Vertical strabismus
H50.2 [45533348]
H50.2 [45533348]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Counselling and guidance related to growth and development
SPAT1303 [2001700404]
SPAT1303 [2001700404]
3.4e-01
7.5e-01
—
—
—
—
5.0e-01
cases:3.41%
controls:2.45%
cases:2.27%
controls:1.08%
—
—
—
—
—
—
—
—
cases:2.95%
controls:1.80%
12
86
340
3421
8
38
344
3469
—
—
—
—
10
61
329
3322
influenza, inactivated, split virus or surface antigen
J07BB02 [21601335]
J07BB02 [21601335]
4.8e-01
2.1e-01
—
—
-1.0e+50
6.0e-01
4.9e-02
cases:5.68%
controls:3.59%
cases:3.98%
controls:3.25%
—
—
—
—
cases:0.00%
controls:0.43%
cases:5.68%
controls:3.19%
cases:12.09%
controls:11.59%
20
126
332
3381
14
114
338
3393
—
—
0
15
352
3492
20
111
332
3374
41
392
298
2991
diphtheria-pertussis-poliomyelitis-tetanus
J07CA02 [21601373]
J07CA02 [21601373]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
352
3497
—
—
—
—
—
—
Application of soft bandage
SPAT1211 [2001700312]
SPAT1211 [2001700312]
3.8e-02
3.1e-01
-1.0e+50
—
-1.0e+50
2.0e-01
5.2e-02
cases:2.84%
controls:2.74%
cases:1.70%
controls:1.25%
cases:0.00%
controls:0.17%
—
—
cases:0.00%
controls:0.17%
cases:1.70%
controls:1.41%
cases:4.72%
controls:4.49%
10
96
342
3411
6
44
346
3463
0
6
352
3501
—
0
6
352
3501
6
49
346
3436
16
152
323
3231
Blood test
-34 [2002000105]
-34 [2002000105]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.57%
—
—
—
—
—
—
—
0
20
352
3465
—
Other anomaly in the position of the teeth
K07.38 [2000502781]
K07.38 [2000502781]
1.5e+00
—
—
1.0e+50
—
—
—
cases:1.70%
controls:0.40%
—
—
—
—
cases:1.99%
controls:0.00%
—
—
—
—
—
—
6
14
346
3493
—
—
7
0
345
3507
—
—
—
Preventive oral care by dental hygienist
SCF02 [2001310319]
SCF02 [2001310319]
2.9e-01
—
—
—
—
1.3e+00
1.2e+00
cases:4.83%
controls:3.65%
—
—
—
—
—
—
—
—
cases:2.27%
controls:0.60%
cases:2.06%
controls:0.65%
17
128
335
3379
—
—
—
—
8
21
344
3464
7
22
332
3361
Other provokation of respiratroy tract
XG488 [2001303875]
XG488 [2001303875]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Nose bleed/epistaxis
R06 [2002000887]
R06 [2002000887]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.60%
—
—
—
0
9
352
3498
—
—
—
0
21
352
3464
—
Fracture of tooth, closed
S02.50 [45755761]
S02.50 [45755761]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
352
3498
—
—
—
—
—
—
Epilepsy and comparable convulsive disorders
111 [2001600111]
111 [2001600111]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
0
7
352
3500
—
—
—
0
8
352
3477
—
Paediatric Clinical Immunology and Allergy
255 [44777768]
255 [44777768]
-3.2e-01
—
-1.0e+50
—
—
—
4.6e-01
cases:1.70%
controls:2.34%
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:1.77%
controls:1.12%
6
82
346
3425
—
0
7
352
3500
—
—
—
6
38
333
3345
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
-6.0e-02
2.2e-01
3.5e-02
—
8.5e-02
9.7e-02
2.2e-02
cases:9.38%
controls:9.89%
cases:9.38%
controls:7.64%
cases:2.27%
controls:2.20%
—
—
cases:1.70%
controls:1.57%
cases:9.09%
controls:8.32%
cases:33.92%
controls:33.43%
33
347
319
3160
33
268
319
3239
8
77
344
3430
—
6
55
346
3452
32
290
320
3195
115
1131
224
2252
Removal of sutures
SPAT1153 [2001700254]
SPAT1153 [2001700254]
—
—
—
—
—
—
6.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.54%
controls:1.95%
—
—
—
—
—
—
12
66
327
3317
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
-6.0e-02
2.6e-01
2.2e-02
—
8.5e-02
1.1e-01
1.8e-02
cases:9.38%
controls:9.89%
cases:9.66%
controls:7.64%
cases:2.27%
controls:2.22%
—
—
cases:1.70%
controls:1.57%
cases:9.09%
controls:8.24%
cases:33.92%
controls:33.52%
33
347
319
3160
34
268
318
3239
8
78
344
3429
—
6
55
346
3452
32
287
320
3198
115
1134
224
2249
Other ultrasound examination
XX9XE [2001311056]
XX9XE [2001311056]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Other specified joint disorders
M25.8 [45543559]
M25.8 [45543559]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Suture of skin of upper limb
QCB00 [2001309902]
QCB00 [2001309902]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
352
3498
—
—
—
—
—
—
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 [2002330116]
SMOKING-1-1-0 [2002330116]
—
—
—
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.00%
—
—
—
—
—
—
6
0
333
3383
Administrative procedure
-62 [2002000133]
-62 [2002000133]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
352
3498
—
—
—
—
—
—
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
11090-8 [3016921]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Remote contact by phone
ZYC01 [2001311579]
ZYC01 [2001311579]
—
-1.0e+50
—
—
—
—
1.5e+00
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.47%
—
0
8
352
3499
—
—
—
—
7
16
332
3367
Familial delayed puberty
E30.00 [2000501479]
E30.00 [2000501479]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
0
9
339
3374
ferrous glycine sulfate; oral
B03AA01 [21601080]
B03AA01 [21601080]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
0
7
352
3500
—
—
—
—
—
Reinsertion of meniscus of knee, arthroscopic
NGD25 [2001308113]
NGD25 [2001308113]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Other allergic rhinitis
J30.3 [45538477]
J30.3 [45538477]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
0
11
352
3496
—
—
—
—
—
Passage examination of small bowell with X-ray
JF1AB [2001304810]
JF1AB [2001304810]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Removal of internal fixation device from elbow or forearm
NCU20 [2001307549]
NCU20 [2001307549]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Preventive oral care by dental hygienist or dental assistant, restricted
SCF01 [2001310318]
SCF01 [2001310318]
—
6.2e-01
—
—
—
—
—
—
—
cases:1.42%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
—
5
27
347
3480
—
—
—
—
—
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
11156-7 [3008757]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.33%
0
5
352
3502
0
6
352
3501
—
—
—
—
0
11
339
3372
papillomavirus (human types 16, 18)
J07BM02 [21601368]
J07BM02 [21601368]
3.5e-01
5.0e-01
-1.0e+50
—
—
2.7e-01
-8.3e-02
cases:5.40%
controls:3.85%
cases:4.83%
controls:2.99%
cases:0.00%
controls:0.71%
—
—
—
—
cases:5.40%
controls:4.19%
cases:5.60%
controls:6.06%
19
135
333
3372
17
105
335
3402
0
25
352
3482
—
—
19
146
333
3339
19
205
320
3178
Fracture of upper end of humerus
S42.2 [45544677]
S42.2 [45544677]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
—
—
0
16
352
3491
—
—
—
—
—
—
Measurement of expired nitric oxide
444642008 [40480257]
444642008 [40480257]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.74%
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.38%
0
26
352
3481
0
7
352
3500
—
—
—
0
9
352
3476
0
13
339
3370
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
—
—
—
—
—
—
6.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.77%
—
—
—
—
—
—
5
26
334
3357
Ambulatory ECG
XF404 [2001303370]
XF404 [2001303370]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
0
10
352
3497
—
—
—
—
—
Prominent ear
Q17.5 [45606731]
Q17.5 [45606731]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
352
3499
—
—
—
—
—
—
Lump/swelling localized
S04 [2002000969]
S04 [2002000969]
—
—
—
—
—
—
4.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.06%
controls:1.36%
—
—
—
—
—
—
7
46
332
3337
Other oral or dental procedure, restricted
SXC02 [2001310583]
SXC02 [2001310583]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Dermatitis/atopic eczema
S87 [2002001051]
S87 [2002001051]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
0
6
352
3479
—
Mixed specific developmental disorders
F83 [45595922]
F83 [45595922]
—
—
-1.0e+50
—
—
-1.0e+50
-1.0e+50
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
cases:0.00%
controls:0.49%
cases:0.00%
controls:0.74%
—
—
0
7
352
3500
—
—
0
17
352
3468
0
25
339
3358
Iron deficiency
E61.1 [45595821]
E61.1 [45595821]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
0
8
339
3375
carbamide, combinations
D02AE51 [21601976]
D02AE51 [21601976]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Paten or persistent foramen ovale
Q21.11 [2000503271]
Q21.11 [2000503271]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Simple partial seizures with secondary generalization
G40.12 [2000502137]
G40.12 [2000502137]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.20%
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:0.00%
controls:0.20%
cases:0.00%
controls:0.35%
0
7
352
3500
0
7
352
3500
—
—
—
0
7
352
3478
0
12
339
3371
Internal fixation of fracture of knee or lower leg using intramedullary nail, other or unspecified
NGJ60 [2001308151]
NGJ60 [2001308151]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Cone beam imaging of teeth and jaws (1–2 quarters)
EB1BI [2001301908]
EB1BI [2001301908]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
intermediate-acting sulfonamides - combinations
J01EC20 [21602948]
J01EC20 [21602948]
4.8e-01
—
—
—
—
-1.0e+50
—
cases:1.42%
controls:0.88%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
5
31
347
3476
—
—
—
—
0
10
352
3475
—
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
—
—
—
—
—
—
6.6e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.26%
controls:7.77%
—
—
—
—
—
—
28
263
311
3120
Cutaneous abscess, furuncle and carbuncle of trunk
L02.2 [45586751]
L02.2 [45586751]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
0
8
339
3375
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
2.2e-02
1.7e-02
-1.0e+50
—
—
8.3e-02
8.5e-02
cases:5.97%
controls:5.85%
cases:1.42%
controls:1.40%
cases:0.00%
controls:0.29%
—
—
—
—
cases:2.27%
controls:2.09%
cases:7.96%
controls:7.36%
21
205
331
3302
5
49
347
3458
0
10
352
3497
—
—
8
73
344
3412
27
249
312
3134
Urinary tract ultrasound examination
KH1AE [2001306329]
KH1AE [2001306329]
1.1e+00
—
—
—
—
—
—
cases:1.70%
controls:0.57%
—
—
—
—
—
—
—
—
—
—
—
—
6
20
346
3487
—
—
—
—
—
—
Examination of postural anomaly
SPAT1213 [2001700314]
SPAT1213 [2001700314]
4.7e-02
1.2e-01
—
—
—
4.9e-01
6.9e-01
cases:5.40%
controls:5.16%
cases:3.13%
controls:2.79%
—
—
—
—
—
—
cases:5.11%
controls:3.19%
cases:7.37%
controls:3.84%
19
181
333
3326
11
98
341
3409
—
—
—
18
111
334
3374
25
130
314
3253
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
—
—
—
—
—
—
3.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.47%
controls:1.06%
—
—
—
—
—
—
5
36
334
3347
Chromosomal abnormality, unspecified
Q99.9 [45563285]
Q99.9 [45563285]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
0
9
339
3374
Conjunctivitis, unspecified
H10.9 [45591253]
H10.9 [45591253]
—
-1.0e+50
—
—
—
—
9.7e-01
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.47%
controls:0.56%
—
0
7
352
3500
—
—
—
—
5
19
334
3364
Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
29775-4 [3014326]
29775-4 [3014326]
3.8e-01
—
—
—
—
9.2e-01
—
cases:1.70%
controls:1.17%
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.69%
—
—
6
41
346
3466
—
—
—
—
6
24
346
3461
—
C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30522-7 [3010156]
30522-7 [3010156]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
0
7
339
3376
Sprain and strain of ankle
S93.4 [45550848]
S93.4 [45550848]
—
—
—
—
—
—
3.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.31%
controls:3.78%
—
—
—
—
—
—
18
128
321
3255
Concussion
S06.0 [45582805]
S06.0 [45582805]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
0
13
352
3494
—
—
—
0
12
352
3473
—
Hematology
82 [38004501]
82 [38004501]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
Obesity due to excess calories
E66.0 [45581372]
E66.0 [45581372]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
cefadroxil; oral
J01DB05 [21602874]
J01DB05 [21602874]
1.7e-02
-1.0e+50
—
—
—
-1.0e+50
—
cases:1.42%
controls:1.40%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
5
49
347
3458
0
9
352
3498
—
—
—
0
7
352
3478
—
Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
29662-4 [3012220]
29662-4 [3012220]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
13
352
3494
—
—
—
—
—
—
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
1.0e+00
—
—
—
—
—
1.6e-01
cases:1.42%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
cases:5.31%
controls:4.55%
5
18
347
3489
—
—
—
—
—
18
154
321
3229
Lumbar spine extensive MRI examination with high intensity magnet
NA3CG [2001307039]
NA3CG [2001307039]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
—
—
—
—
—
—
3.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.83%
controls:2.63%
—
—
—
—
—
—
13
89
326
3294
clindamycin
D10AF01 [21602305]
D10AF01 [21602305]
—
—
—
—
—
—
3.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.36%
controls:1.68%
—
—
—
—
—
—
8
57
331
3326
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
FXA00 [2001303347]
FXA00 [2001303347]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
352
3497
—
—
—
—
—
—
Protein/Creatinine [Ratio] in Urine
34366-5 [3045462]
34366-5 [3045462]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
0
10
352
3475
—
Unspecified injury of shoulder and upper arm
S49.9 [45588163]
S49.9 [45588163]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
6
339
3377
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
1.5e-01
4.9e-01
4.0e-01
—
4.1e-01
2.6e-01
1.0e-01
cases:6.82%
controls:5.93%
cases:6.82%
controls:4.28%
cases:3.13%
controls:2.11%
—
—
cases:2.84%
controls:1.91%
cases:5.68%
controls:4.45%
cases:12.09%
controls:11.06%
24
208
328
3299
24
150
328
3357
11
74
341
3433
—
10
67
342
3440
20
155
332
3330
41
374
298
3009
Dental calculus supragingival
K03.64 [2000502689]
K03.64 [2000502689]
2.7e-01
-1.4e-02
—
—
—
-1.7e-03
1.1e-01
cases:5.11%
controls:3.93%
cases:2.84%
controls:2.88%
—
—
—
—
—
—
cases:3.41%
controls:3.41%
cases:16.22%
controls:14.75%
18
138
334
3369
10
101
342
3406
—
—
—
12
119
340
3366
55
499
284
2884
hydrocortisone and antiinfectives
S02CA03 [21605175]
S02CA03 [21605175]
1.0e-01
—
—
—
—
—
-5.3e-02
cases:2.56%
controls:2.31%
—
—
—
—
—
—
—
—
—
—
cases:3.54%
controls:3.72%
9
81
343
3426
—
—
—
—
—
12
126
327
3257
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
F32.10 [2000501980]
-1.0e+50
—
—
—
—
—
-1.7e-01
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:3.13%
0
11
352
3496
—
—
—
—
—
9
106
330
3277
Histone Ab [Presence] in Serum by Immunoblot
56717-2 [40759836]
56717-2 [40759836]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
0
5
352
3502
—
—
—
—
—
0
5
339
3378
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
—
—
—
—
—
—
1.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:2.22%
—
—
—
—
—
—
9
75
330
3308
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
12286-1 [3011288]
—
—
—
—
—
—
6.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.77%
controls:0.95%
—
—
—
—
—
—
6
32
333
3351
Vomiting
D10 [2002000309]
D10 [2002000309]
—
—
—
—
—
—
8.2e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:1.18%
—
—
—
—
—
—
9
40
330
3343
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
2.5e-01
—
—
—
—
7.6e-01
-3.4e-01
cases:1.42%
controls:1.11%
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.80%
cases:2.36%
controls:3.28%
5
39
347
3468
—
—
—
—
6
28
346
3457
8
111
331
3272
Ankle X-ray examination without contrast
NH1AA [2001308235]
NH1AA [2001308235]
—
-1.0e+50
—
—
—
—
2.5e-01
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
—
—
cases:1.77%
controls:1.39%
—
0
12
352
3495
—
—
—
—
6
47
333
3336
Cladosporium herbarum IgE Ab [Units/volume] in Serum
6075-6 [3005136]
6075-6 [3005136]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
352
3499
—
—
—
—
—
—
Intra-abdominal and pelvic swelling, mass and lump
R19.0 [45544132]
R19.0 [45544132]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
352
3502
—
—
—
—
—
—
Chronic disease of tonsils and adenoids, unspecified
J35.9 [45533548]
J35.9 [45533548]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
0
6
352
3501
—
—
—
—
0
5
339
3378
Developmental disorder of scholastic skills, unspecified
F81.9 [45581474]
F81.9 [45581474]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
0
5
339
3378
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-8.9e-02
2.4e-01
1.8e-01
—
1.3e-01
2.0e-02
1.8e-01
cases:8.52%
controls:9.24%
cases:8.24%
controls:6.62%
cases:2.27%
controls:1.91%
—
—
cases:1.42%
controls:1.25%
cases:7.10%
controls:6.97%
cases:28.61%
controls:25.16%
30
324
322
3183
29
232
323
3275
8
67
344
3440
—
5
44
347
3463
25
243
327
3242
97
851
242
2532
betamethasone
S02BA07 [21605169]
S02BA07 [21605169]
—
—
—
—
—
—
-1.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.54%
controls:4.02%
—
—
—
—
—
—
12
136
327
3247
Nausea and vomiting
R11 [45539317]
R11 [45539317]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
9
352
3498
—
—
—
—
—
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
G40.19 [2000502138]
G40.19 [2000502138]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.37%
cases:0.00%
controls:0.29%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.41%
0
13
352
3494
0
10
352
3497
—
—
—
0
6
352
3479
0
14
339
3369
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
9835/3-C42.1 [44503066]
9835/3-C42.1 [44503066]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
352
3496
—
—
—
—
—
—
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
9
22
4.17
2.90
3.2
2.3
—
—
—
0
0
29
166
1.81
2.23
21.7
16.5
1.14
1.04
mg/l
0.48
29
161
11
43
2.61
2.10
2.0
2.6
—
—
—
0
0
5
10
5.05
2.07
1.0
1.3
—
—
—
0
0
9
34
2.69
1.88
5.0
7.2
3.80
5.71
pmol/l
—
9
34
33
217
1.57
1.58
2.4
1.8
—
—
—
0
0
33
217
1.57
1.58
2.6
1.9
—
—
—
0
0
44
311
1.47
1.53
2.6
1.9
—
—
—
0
0
7
29
2.44
1.40
1.3
2.0
0.73
0.64
e9/l
—
7
29
29
424
0.66
1.37
1.4
1.2
1.19
6.88
u/ml
1.83
12
149
6
23
2.64
1.37
2.5
1.8
—
—
—
0
0
5
17
2.97
1.36
1.4
2.4
0.60
0.65
index
—
5
17
323
3331
0.65
1.35
18.7
14.7
133.58
134.59
g/l
0.73
317
3285
36
251
1.48
1.35
1.6
1.8
—
—
—
0
0
43
311
1.44
1.34
4.7
4.6
29.43
29.56
s
0.08
43
306
15
83
1.84
1.33
15.3
21.9
0.67
0.66
%
0.04
15
83
6
25
2.42
1.25
3.2
1.4
—
—
—
0
0
9
45
2.03
1.24
1.1
1.2
—
—
—
0
0
9
45
2.03
1.24
1.1
1.2
—
—
—
0
0
11
56
2.00
1.23
1.2
1.6
—
—
—
0
0
120
1029
1.25
1.18
15.0
9.3
1.22
1.22
mmol/l
0.01
108
932
78
635
1.29
1.17
2.4
2.7
73.10
57.17
u/l
0.44
70
585
91
757
1.27
1.15
3.7
2.6
1.02
1.02
kg/l
0.08
65
437
8
40
2.02
1.12
2.1
1.5
—
—
—
0
0
271
2855
0.78
1.12
17.0
12.3
333.80
334.04
g/l
0.16
264
2827
324
3328
0.69
1.08
18.5
14.5
4.54
4.59
e12/l
1.24
313
3236
324
3328
0.69
1.08
19.3
15.2
39.75
41.17
%
0.76
317
3282
324
3327
0.69
1.06
18.4
14.5
88.27
87.86
fl
1.04
318
3281
12
67
1.82
1.06
24.3
4.8
23.89
24.38
mmol/l
0.21
12
60
45
347
1.34
1.00
18.7
9.2
5.88
5.87
kpa
0.04
45
335
324
3324
0.70
0.99
18.5
14.6
270.23
267.67
e9/l
0.31
314
3233
5
23
2.19
0.98
1.6
1.3
—
—
—
0
0
9
50
1.82
0.97
1.6
1.4
—
—
—
0
0
91
1059
0.81
0.95
2.5
2.5
—
—
—
0
0
60
732
0.78
0.95
4.9
3.6
0.08
0.25
e6/l
2.17
47
516
6
119
0.50
0.95
1.0
1.0
1.40
1.51
g/l
—
6
119
107
926
1.22
0.95
16.9
9.9
1.22
1.22
mmol/l
0.06
102
876
14
86
1.65
0.92
3.3
3.3
17.11
24.51
mu/l
0.47
14
76
7
126
0.55
0.90
1.6
1.4
—
—
—
0
0
89
760
1.23
0.90
4.5
3.2
0.00
0.01
estimate
0.80
32
316
14
87
1.63
0.89
16.3
21.0
96.58
94.97
%
0.96
14
87
21
295
0.69
0.85
1.1
1.3
2.54
3.09
mmol/l
1.53
15
180
36
462
0.75
0.84
5.5
3.0
0.46
1.22
e6/l
2.43
25
223
275
2868
0.82
0.83
12.7
9.1
66.25
64.32
umol/l
0.65
268
2821
34
437
0.75
0.81
5.7
3.2
4.14
5.45
e6/l
0.21
22
198
38
296
1.32
0.81
13.4
9.6
23.94
23.57
mmol/l
0.46
38
296
10
58
1.75
0.80
2.3
1.5
—
—
—
0
0
291
3015
0.80
0.80
4.2
4.1
—
—
—
0
0
123
1096
1.19
0.80
4.1
2.8
0.00
0.01
estimate
0.69
30
270
12
74
1.64
0.79
2.3
2.1
—
—
—
0
0
0
26
0.00
0.78
0.0
1.1
—
7.88
—
0
26
35
445
0.76
0.78
1.2
1.3
8.22
15.43
iu/ml
—
8
98
99
868
1.20
0.76
3.4
2.5
0.00
0.01
estimate
0.50
28
276
18
124
1.48
0.76
13.3
19.5
-1.41
-0.13
mmol/l
0.55
13
100
41
326
1.29
0.76
14.5
8.8
5.20
4.93
kpa
0.38
41
317
5
24
2.10
0.75
1.6
1.3
—
—
—
0
0
5
24
2.10
0.75
1.6
1.3
—
—
—
0
0
28
365
0.75
0.74
1.2
1.4
2.84
3.23
ratio
1.21
20
239
5
25
2.01
0.73
1.4
1.2
—
—
—
0
0
13
192
0.66
0.70
2.1
1.6
0.09
0.21
mg/l
—
6
77
13
85
1.55
0.70
17.1
21.2
22.92
23.78
mmol/l
0.38
13
85
275
2855
0.84
0.69
9.8
8.0
21.80
23.55
u/l
1.35
261
2762
7
119
0.58
0.69
1.0
1.0
0.80
0.81
g/l
—
7
119
39
313
1.28
0.69
16.6
14.2
25.00
24.85
mmol/l
0.11
39
313
14
94
1.51
0.67
7.8
11.0
0.59
0.63
%
0.25
14
94
16
111
1.46
0.67
22.3
10.5
128.00
130.90
g/l
0.25
16
105
35
278
1.29
0.67
1.5
1.7
—
—
—
0
0
265
2757
0.85
0.66
16.6
12.8
13.15
12.98
%
1.39
258
2721
11
70
1.59
0.66
2.1
2.1
—
—
—
0
0
206
2183
0.87
0.65
7.8
6.6
109.47
112.11
ml/min/173m2
0.92
160
1725
34
270
1.29
0.65
1.3
1.3
333.11
243.50
miu/ml
0.55
19
137
5
29
1.73
0.64
1.0
1.1
524.60
760.01
mu/l
—
5
29
132
1441
0.87
0.63
2.8
2.7
—
—
—
0
0
5
30
1.68
0.61
1.0
1.1
70.60
73.43
%
—
5
30
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
22
285
0.76
0.58
2.3
2.0
34.17
6.88
u/l
0.45
12
215
16
115
1.41
0.57
2.8
3.5
92.60
95.86
ml/min/173m2
—
10
37
249
2592
0.87
0.57
14.7
9.5
3.85
3.85
mmol/l
0.06
233
2505
6
36
1.68
0.57
2.0
1.3
12.83
12.89
%
—
6
36
6
38
1.59
0.54
2.0
1.6
—
—
—
0
0
84
937
0.86
0.53
2.2
2.2
—
—
—
0
0
162
1728
0.88
0.52
12.4
8.5
3.73
3.73
e9/l
0.00
135
1489
75
666
1.16
0.51
3.5
2.4
2.38
2.37
mmol/l
0.14
69
618
25
200
1.27
0.48
2.7
4.5
238.89
471.28
ng/l
0.96
19
149
264
2725
0.88
0.47
5.0
4.7
1.76
1.80
mu/l
0.32
254
2600
251
2598
0.88
0.46
14.5
9.5
139.38
139.50
mmol/l
0.52
234
2520
200
2097
0.89
0.46
2.9
2.8
4.26
4.40
mmol/l
1.64
193
2011
144
1346
1.12
0.45
8.4
6.3
5.91
5.93
mmol/l
0.05
128
1190
77
852
0.88
0.44
2.6
2.8
2.28
2.41
mg/l
0.26
70
739
74
820
0.88
0.43
4.9
3.8
—
—
—
0
0
8
56
1.44
0.43
1.1
1.8
8.59
6.91
mmol/l
—
8
56
128
1370
0.90
0.42
2.5
2.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
41.63
—
0
15
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
151
1598
0.90
0.40
2.3
2.1
—
—
—
0
0
157
1483
1.11
0.39
4.6
3.2
0.00
4.71
estimate
0.50
34
320
43
374
1.17
0.39
1.6
1.4
—
—
—
0
0
9
66
1.37
0.38
4.0
1.8
—
—
—
0
0
23
188
1.24
0.38
1.5
1.6
1292.53
1029.11
nmol/l
0.51
15
143
9
67
1.35
0.38
1.6
1.2
—
—
—
0
0
155
1466
1.10
0.38
4.6
3.2
0.00
0.00
estimate
-0.00
35
330
9
68
1.33
0.38
1.3
1.1
—
—
—
0
0
10
72
1.40
0.37
3.8
1.8
—
—
—
0
0
9
71
1.27
0.36
1.0
1.2
30.11
33.09
u/l
—
9
66
200
2081
0.91
0.36
2.9
2.7
2.51
2.63
mmol/l
1.63
191
1987
6
41
1.47
0.36
3.2
1.3
—
—
—
0
0
183
1911
0.91
0.35
4.1
4.2
6.49
6.98
mm/h
0.44
174
1779
6
43
1.40
0.35
3.0
1.7
—
—
—
0
0
6
43
1.40
0.35
2.0
1.5
—
—
—
0
0
24
286
0.83
0.35
1.3
1.6
65.57
63.83
ug/l
0.06
24
256
25
209
1.21
0.35
13.7
13.1
106.00
105.60
mmol/l
0.33
25
209
209
2168
0.91
0.35
2.7
2.5
5.16
5.31
mmol/l
2.90
200
1993
201
1933
1.09
0.33
3.5
3.4
46.00
45.28
ug/l
0.05
194
1836
19
155
1.24
0.33
2.5
2.1
—
—
—
0
0
156
1487
1.09
0.31
4.6
3.3
0.00
0.00
estimate
-0.00
33
317
18
147
1.24
0.31
1.3
1.4
—
—
—
0
0
55
606
0.89
0.31
3.3
2.7
—
—
—
0
0
13
102
1.28
0.30
2.0
1.9
—
—
—
0
0
200
2070
0.92
0.29
2.8
2.6
1.42
1.43
mmol/l
0.15
191
1976
170
1770
0.92
0.29
5.0
3.6
27.99
23.86
u/l
0.40
163
1700
14
173
0.80
0.29
1.1
1.2
—
38.26
—
0
5
63
577
1.11
0.29
2.3
2.4
7941.38
6477.57
u/l
0.11
21
204
15
183
0.81
0.28
1.5
1.3
—
—
—
0
0
9
118
0.76
0.28
1.7
1.4
—
—
—
0
0
16
131
1.23
0.27
2.2
1.8
—
—
—
0
0
15
122
1.24
0.27
4.8
3.3
1.23
1.23
mmol/l
0.01
15
102
290
2950
0.91
0.26
11.8
9.9
21.22
20.98
mg/l
0.05
223
2175
22
255
0.85
0.25
1.3
1.5
1.02
0.93
ratio
0.51
16
160
22
255
0.85
0.25
1.3
1.5
1.15
1.17
ratio
0.03
16
160
22
255
0.85
0.25
1.3
1.5
1.12
1.21
ratio
0.23
16
160
43
389
1.12
0.25
1.1
1.1
—
—
—
0
0
14
169
0.82
0.24
2.6
2.4
—
—
—
0
0
14
169
0.82
0.24
1.6
1.3
—
—
—
0
0
41
371
1.12
0.24
4.4
2.7
14.29
14.84
umol/l
0.20
41
347
5
38
1.32
0.23
3.6
1.7
—
—
—
0
0
31
276
1.14
0.23
9.6
6.4
0.88
0.92
mmol/l
0.02
16
193
162
1678
0.94
0.23
7.8
5.5
86.22
83.84
u/l
0.22
153
1573
28
248
1.14
0.22
1.5
1.5
55.12
56.49
ug/l
0.07
28
248
5
42
1.19
0.21
3.2
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
33
300
1.11
0.18
1.2
1.2
—
3.32
—
0
5
31
281
1.11
0.18
5.5
3.0
19.80
23.18
%
0.84
31
266
22
247
0.88
0.18
1.3
1.5
—
—
—
0
0
14
163
0.85
0.17
1.2
1.2
—
5.24
—
0
12
16
184
0.86
0.17
1.6
1.7
—
—
—
0
0
13
110
1.19
0.17
2.0
1.9
2.53
3.80
iu/l
—
8
50
5
67
0.74
0.17
1.6
2.7
0.35
0.69
nmol/l
—
5
57
121
1254
0.95
0.17
3.8
2.9
68.36
65.39
nmol/l
0.69
114
1168
17
149
1.15
0.16
8.2
5.3
156.18
173.13
%
0.41
17
143
6
76
0.79
0.16
1.2
1.2
—
24.05
—
0
8
23
207
1.12
0.15
2.1
4.3
224.61
228.86
u/l
0.12
23
202
11
129
0.85
0.15
1.2
1.2
—
—
—
0
0
7
90
0.77
0.14
1.1
1.1
—
2.64
—
0
9
16
141
1.14
0.14
1.8
2.0
—
—
—
0
0
9
109
0.82
0.13
1.1
1.4
—
—
—
0
0
187
1833
1.04
0.13
2.9
3.0
34.45
35.06
mmol/mol
0.53
178
1736
11
127
0.86
0.12
1.1
1.1
—
—
—
0
0
10
85
1.18
0.12
1.0
1.1
0.90
4.07
eliau/ml
—
5
33
36
384
0.93
0.12
1.4
1.3
148.08
133.11
u/ml
—
10
138
55
526
1.05
0.10
2.9
2.9
10.44
11.65
e6/l
0.23
46
471
116
1190
0.96
0.10
3.2
3.1
—
—
estimate
—
0
0
133
1300
1.04
0.10
1.7
1.7
1.27
2.46
u/ml
0.96
31
297
19
207
0.91
0.10
2.2
1.5
—
62.01
—
0
7
6
57
1.05
0.08
1.2
1.3
—
—
—
0
0
22
205
1.08
0.08
1.6
2.0
—
—
—
0
0
85
832
1.03
0.05
1.5
1.6
95.82
97.98
pmol/l
0.19
41
443
187
1890
0.98
0.05
2.5
2.5
1.04
1.09
mmol/l
0.47
182
1805
10
110
0.91
0.05
1.1
1.1
—
—
—
0
0
52
506
1.03
0.04
3.5
2.8
2.41
0.89
mg/l
0.40
36
322
97
986
0.98
0.04
8.5
5.8
10.04
10.36
umol/l
0.16
87
913
36
348
1.04
0.04
1.3
1.3
—
—
—
0
0
27
259
1.05
0.04
2.0
2.0
21.06
7.82
iu/l
0.43
17
196
79
780
1.02
0.02
1.6
1.8
1.20
1.18
mmol/l
0.11
69
717
59
581
1.02
0.02
1.5
1.5
—
—
—
0
0
30
292
1.03
0.02
1.3
1.4
416.28
25572936.64
pmol/l
0.50
25
262
16
166
0.96
0.00
1.6
1.5
—
—
—
0
0
20
194
1.03
0.00
1.4
1.4
—
—
—
0
0
48
479
1.00
0.00
2.0
1.9
6.10
12.13
ng/l
—
10
117
32
317
1.01
0.00
1.8
2.6
354.92
717.75
ng/l
0.77
12
116
57
573
0.99
0.00
1.5
1.6
985.65
940.02
mu/l
0.18
52
525
245
2455
0.99
0.00
4.2
3.9
14.34
14.36
pmol/l
0.04
223
2156
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
6
65
0.92
0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
1.20
—
0
6
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
19.35
—
0
6
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
7
76
0.92
-0.00
1.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
10.13
—
0
8
5
59
0.85
-0.00
1.8
1.5
0.40
0.53
e9/l
—
5
59
0
7
0.00
-0.00
0.0
3.0
—
25.43
—
0
7
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: K11_MAXIL_CANINE_OPER – Palatinal maxillary operation
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).